000 01848 a2200541 4500
005 20250513155725.0
264 0 _c19981229
008 199812s 0 0 eng d
022 _a0002-9440
024 7 _a10.1016/S0002-9440(10)65692-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGermolec, D R
245 0 0 _aArsenic enhancement of skin neoplasia by chronic stimulation of growth factors.
_h[electronic resource]
260 _bThe American journal of pathology
_cDec 1998
300 _a1775-85 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAntibodies
_xpharmacology
650 0 4 _aArsenic
_xadministration & dosage
650 0 4 _aCell Division
650 0 4 _aFemale
650 0 4 _aGranulocyte-Macrophage Colony-Stimulating Factor
_ximmunology
650 0 4 _aGrowth Substances
_ximmunology
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aMice
650 0 4 _aMice, Transgenic
650 0 4 _aPapilloma
_xchemically induced
650 0 4 _aRNA, Messenger
_xmetabolism
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aSkin Diseases
_xchemically induced
650 0 4 _aSkin Neoplasms
_xchemically induced
650 0 4 _aTetradecanoylphorbol Acetate
_xadministration & dosage
650 0 4 _aTissue Distribution
650 0 4 _aTransforming Growth Factor alpha
_ximmunology
700 1 _aSpalding, J
700 1 _aYu, H S
700 1 _aChen, G S
700 1 _aSimeonova, P P
700 1 _aHumble, M C
700 1 _aBruccoleri, A
700 1 _aBoorman, G A
700 1 _aFoley, J F
700 1 _aYoshida, T
700 1 _aLuster, M I
773 0 _tThe American journal of pathology
_gvol. 153
_gno. 6
_gp. 1775-85
856 4 0 _uhttps://doi.org/10.1016/S0002-9440(10)65692-1
_zAvailable from publisher's website
999 _c9810080
_d9810080